Docking-Based Virtual Screening and Molecular Dynamics Simulations of Quercetin Analogs as Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors of Mycobacterium tuberculosis

نویسندگان

چکیده

The emergence of multidrug-resistant Mycobacterium tuberculosis (MTB) has become a major problem in treating (TB) and shows the need to develop new efficient drugs for better TB control. This study aimed use silico techniques discover potential inhibitors Enoyl-[acyl-carrier-protein] reductase (InhA), which controls mycobacterial cell wall construction. Initially, 391 quercetin analogs present KNApSAck_3D database were selected, filters sequentially applied by docking-based virtual screening. After recategorizing variables (bond energy prediction molecular interaction, including hydrogen bond hydrophobic bond), compounds C00013874, C00006532, C00013887 selected as hit ligands. These showed great contributions, each ligand, 100 ns dynamic simulations performed, binding free was calculated. C00013874 demonstrated greatest capacity InhA enzyme inhibition with ?Gbind = ?148.651 kcal/mol compare NAD (native ligand) presented ?87.570 kcal/mol. data are preliminary studies might be suitable candidate further experimental analysis.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Development of 1,2,4-triazole-5-thione derivatives as potential inhibitors of enoyl acyl carrier protein reductase (InhA) in tuberculosis.

Tuberculosis (TB) ranks second, next to AIDS making it most formidable disease if the present age. One of the crucial enzymes involved in cell wall synthesis of Mycobacterium tuberculosis, InhA (enoyl acyl carrier protein reductase) has been authenticated as an effective target for anti-mycobacterial drug development. In the current work, we have developed novel derivatives of 1,2,4-triazole-5-...

متن کامل

Development of 1,2,4-triazole-5-thione derivatives as potential inhibitors of enoyl acyl carrier protein reductase (InhA) in tuberculosis.

Tuberculosis (TB) ranks second, next to AIDS making it most formidable disease if the present age. One of the crucial enzymes involved in cell wall synthesis of Mycobacterium tuberculosis, InhA (enoyl acyl carrier protein reductase) has been authenticated as an effective target for anti-mycobacterial drug development. In the current work, we have developed novel derivatives of 1,2,4-triazole-5-...

متن کامل

Screening of Annona muricata for E. coli enoyl acyl carrier protein reductase inhibitors by molecular docking

Chemical compounds isolated from plant sources are most common natural products that exhibit a broad spectrum of antibacterial activity. In order to decipher antibacterial activity of A.nuricata compounds and growth inhibitors, molecular docking work was carried out to identify active compounds against NADH-dependent E.coli enoyl-ACPreductase which is involved in mycolicacid biosynthesis. Annon...

متن کامل

A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis.

InhA, the enoyl-ACP reductase in Mycobacterium tuberculosis is an attractive target for the development of novel drugs against tuberculosis, a disease that kills more than two million people each year. InhA is the target of the current first line drug isoniazid for the treatment of tuberculosis infections. Compounds that directly target InhA and do not require activation by the mycobacterial ca...

متن کامل

Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.

Isoniazid resistance is a serious threat in the battle against the treatment of multi-drug resistant tuberculosis (MDR-TB) and extremely drug-resistant tuberculosis (XDR-TB). Isoniazid is an inhibitor of enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis, which is an important and functional enzyme of the type II fatty acid synthesis system and important therapeutic targe...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Scientia Pharmaceutica

سال: 2021

ISSN: ['0036-8709', '2218-0532']

DOI: https://doi.org/10.3390/scipharm89020020